Home/Filings/4/0001104659-21-047486
4//SEC Filing

Duncan Gregory Scott 4

Accession 0001104659-21-047486

CIK 0001818844other

Filed

Apr 6, 8:00 PM ET

Accepted

Apr 7, 1:59 PM ET

Size

4.7 KB

Accession

0001104659-21-047486

Insider Transaction Report

Form 4
Period: 2021-04-06
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Purchase

    Common Stock

    2021-04-06$6.36/sh+382$2,42919,961 total
Footnotes (1)
  • [F1]This purchase was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2021.

Issuer

Virios Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1
  • filerCIK 0001831127

Filing Metadata

Form type
4
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 1:59 PM ET
Size
4.7 KB